1. Home
  2. EARN vs BWAY Comparison

EARN vs BWAY Comparison

Compare EARN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

N/A

Current Price

$5.16

Market Cap

189.7M

Sector

Real Estate

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$16.27

Market Cap

337.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EARN
BWAY
Founded
2012
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
337.9M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
EARN
BWAY
Price
$5.16
$16.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$5.88
$23.50
AVG Volume (30 Days)
312.6K
61.3K
Earning Date
11-19-2025
11-11-2025
Dividend Yield
18.64%
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$35,893,000.00
$49,094,000.00
Revenue This Year
$8.43
$330.76
Revenue Next Year
$17.28
$22.24
P/E Ratio
N/A
$53.28
Revenue Growth
43.30
27.08
52 Week Low
$4.33
$7.84
52 Week High
$6.87
$18.18

Technical Indicators

Market Signals
Indicator
EARN
BWAY
Relative Strength Index (RSI) 44.61 46.21
Support Level $5.10 $16.75
Resistance Level $5.20 $17.38
Average True Range (ATR) 0.09 0.75
MACD -0.02 -0.07
Stochastic Oscillator 13.75 21.06

Price Performance

Historical Comparison
EARN
BWAY

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: